Clinical Trial

Continuous Erector Spinae Block Versus Thoracic Epidural Analgesia for the Prevention of Chronic Pain Following Thoracotomy: a Retrospective Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 30, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Post-thoracotomy pain syndrome (PTPS) is a prevalent complication that significantly impacts patients' quality of life, with reported incidence ranging from 25% to 90%. This study evaluated the effectiveness of continuous erector spinae plane (ESP) block compared to thoracic epidural analgesia (TEA), the current gold standard, in preventing PTPS. Our goal was to compare the incidence of PTPS between patients who received ESP block and those who underwent TEA. Additional goals included assessing postoperative pain levels, analgesic consumption, and complications related to the anesthesia techniques.
Trial Details
NCT Number NCT07677540
Lead Sponsor Meir Medical Center
Conditions Thoracic Surgery
Enrollment 34 participants
Start Date 2023-09-12
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-30